Page last updated: 2024-09-05

lu 135252 and Infantile Respiratory Distress Syndrome

lu 135252 has been researched along with Infantile Respiratory Distress Syndrome in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Boemke, W; Busch, T; Hocher, B; Kaisers, U; Lohbrunner, H; Wilkens, K; Wolf, S	1

Trials

1 trial(s) available for lu 135252 and Infantile Respiratory Distress Syndrome

Article	Year
Inhaled endothelin A antagonist improves arterial oxygenation in experimental acute lung injury. Intensive care medicine, 2000, Volume: 26, Issue:9 Topics: Administration, Inhalation; Animals; Disease Models, Animal; Hemodynamics; Humans; Infant, Newborn; Phenylpropionates; Prospective Studies; Pulmonary Gas Exchange; Pyrimidines; Respiratory Distress Syndrome, Newborn; Statistics, Nonparametric; Swine	2000

Article

Year

Inhaled endothelin A antagonist improves arterial oxygenation in experimental acute lung injury.

Intensive care medicine, 2000, Volume: 26, Issue:9

Topics: Administration, Inhalation; Animals; Disease Models, Animal; Hemodynamics; Humans; Infant, Newborn; Phenylpropionates; Prospective Studies; Pulmonary Gas Exchange; Pyrimidines; Respiratory Distress Syndrome, Newborn; Statistics, Nonparametric; Swine

2000